Clinical RoundupFree Baylor researchers develop drug aimed at overcoming cancer drug resistance August 14, 2026Vol.52 No.32
Clinical RoundupFree SANRECO phase II study of divesiran in polycythemia vera meets primary endpoint August 14, 2026Vol.52 No.32
Clinical Roundup Phase III XPORT-EC-042 trial in endometrial cancer does not meet primary endpoint August 07, 2026Vol.52 No.31
Clinical Roundup BRCA-negative patients may still be high-risk for breast cancer, study finds August 07, 2026Vol.52 No.31
Clinical Roundup DELFI liquid biopsy detects liver cancer across diverse international populations, Hopkins-led study finds August 07, 2026Vol.52 No.31
Clinical Roundup Mesothelioma cells rewire genes to resist GNE-7883, study finds August 07, 2026Vol.52 No.31
Clinical Roundup Biobank of tumor models reveals cancers’ weak spots, Nature study finds August 07, 2026Vol.52 No.31
Clinical Roundup Anti-Müllerian hormone may help many women with HR+ breast cancer avoid chemotherapy August 07, 2026Vol.52 No.31
Clinical Roundup How to boost enrollment of Black and Hispanic patients in pediatric clinical trials August 07, 2026Vol.52 No.31
Clinical Roundup Enfortumab vedotin + pembrolizumab improves survival and reduces recurrence risk in muscle-invasive bladder cancer, phase III trial finds July 31, 2026Vol.52 No.30
